georgeclerk
GeorgeClerk / iStockphoto.com
10 October 2017Big PharmaRachel Bradley

After Brexit: new directions for clinical trials

A new regime for clinical trials in Europe is coming into force in 2018. However, there are uncertainties about what clinical trials legislation will apply in the UK once it leaves the EU. This article is a brief summary of the changes that will come into force for businesses based in Europe and for global businesses running clinical trials in Europe, and the potential impact of Brexit.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
15 December 2020   Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.
Big Pharma
29 November 2017   The EU and UK must make progress in Brexit negotiations “as soon as possible”, according to the associations that represent the European and British life sciences industry.
Big Pharma
11 July 2018   The European Medicines Agency has expressed concerns about how prepared medical marketing authorisation holders are for when the UK leaves the EU.

More on this story

Big Pharma
15 December 2020   Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.
Big Pharma
29 November 2017   The EU and UK must make progress in Brexit negotiations “as soon as possible”, according to the associations that represent the European and British life sciences industry.
Big Pharma
11 July 2018   The European Medicines Agency has expressed concerns about how prepared medical marketing authorisation holders are for when the UK leaves the EU.

More on this story

Big Pharma
15 December 2020   Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.
Big Pharma
29 November 2017   The EU and UK must make progress in Brexit negotiations “as soon as possible”, according to the associations that represent the European and British life sciences industry.
Big Pharma
11 July 2018   The European Medicines Agency has expressed concerns about how prepared medical marketing authorisation holders are for when the UK leaves the EU.